CoreMap

Transforming treatment by getting to the heart of the problem

United States · Founded 2016 · $37.0M raised

Founded
2016
Business Model
B2B
Total Funding
$37.0M
Last Round
$37.0M Series CJul 2026
Rounds
1

About

CoreMap develops medical technology to map the electrical patterns underlying atrial fibrillation and support patient-specific ablation treatment. Its platform is intended to help electrophysiologists identify the mechanisms sustaining complex arrhythmias, with the goal of improving the effectiveness of curative therapy. The company is advancing its EP Mapping system through clinical development.

Summary

CoreMap is a Healthcare company based in United States, founded in 2016. It has raised $37.0M in total across 1 round, most recently a $37.0M Series C round in Jul 2026. Investors include Medtronic.

Funding History

Series CSeries CJul 2026
$37.0M

Investors

Similar Companies